27386130
2016 Jun 9
Uterine cervical small cell carcinoma is rare and aggressive with no standardized therapy. A patient bearing the advanced chemo-refractory carcinoma, treated with a tumor vaccine combined with 1 mg/kg of pembrolizumab, showed a transient increase and subsequent sharp decrease of the liver-metastasized lesion to less than half its maximum diameter.
Anti‐PD‐1 antibody; cancer vaccine; radiation therapy; uterine cervical small cell carcinoma.
